Truepill
White-label digital pharmacy, now part of Fuze Health as FuzeRx
100X Meter Early
Think Truepill could go 100X?
Give it a push. One tap per reader each day; the meter tracks buzz here, not quality.
Tell your network you backed Truepill early
Download share card
For founders
Share your listing
Everything you need to send people to Truepill on 100xFounder. Links carry share tags so you can see the visits in your own analytics.
Badge for your site
Shows your live 100X Meter level and links to this page.
Share card
A 1080×1350 image with your current level, sized for Instagram and LinkedIn.
Download share cardReady-to-post captions
We're listed on 100xFounder. Truepill now has a page on the 100X Meter, where readers back the startups they believe in with one tap a day.
If you've used Truepill, a tap or a short review there would mean a lot to the team: https://100xfounder.com/startup/truepill/?utm_source=linkedin&utm_medium=share&utm_campaign=founder-kit
X
Truepill is on the 100xFounder 100X Meter ⚡ Think we could go 100X? One tap a day helps: https://100xfounder.com/startup/truepill/?utm_source=x&utm_medium=share&utm_campaign=founder-kit
Hi! Truepill is listed on 100xFounder. If you like what we're building, tap "100X it" on our page (takes two seconds, once a day): https://100xfounder.com/startup/truepill/?utm_source=whatsapp&utm_medium=share&utm_campaign=founder-kit
Invite your users to back you on the 100X Meter
Each reader can tap once a day. Send this to your users, community or newsletter.
What Truepill does
Truepill was a business-to-business digital pharmacy. Telehealth companies and direct-to-consumer health brands used its API and pharmacies to fill and ship prescriptions under their own brand, and it later added telehealth and at-home testing services. Fierce Healthcare reported that it started out as the pharmacy fulfilment backbone for brands such as Hims and Nurx. Y Combinator’s directory says it was founded in 2017, went through YC in summer 2017, and names Sid Viswanathan as a founder.
Truepill grew quickly during the pandemic. In October 2021 it raised a $142 million Series D at a $1.6 billion valuation, with existing investors Initialized Capital and TI Platform Management taking part, Fierce Healthcare and MobiHealthNews reported. In 2024 home testing company LetsGetChecked acquired Truepill, and in May 2025 the combined business launched as Fuze Health, GenomeWeb reported. Truepill’s old website now redirects to FuzeRx, Fuze Health’s pharmacy service, and Y Combinator lists Truepill’s status as acquired. Separately, the UK health platform Phlo bought Truepill’s UK arm.
FuzeRx describes itself as pharmacy services built for life sciences companies, payers and providers: home dispensing, a virtual pharmacy, hub services and white-label pharmacy through an API, with insurance, FSA/HSA and savings-card payments. It does not publish prices; partners contact the sales team. So this page describes a brand that no longer exists on its own: anyone looking for Truepill’s services today should look at FuzeRx.
We have not used Truepill for this page. It brings together Truepill’s own website and the reporting linked under Sources, and says where each fact comes from. Nothing here is paid placement.
What people use Truepill for
- White-label prescription fulfilment for telehealth brands
- Home delivery of medication
- Pharmacy API integration for digital health apps
- Hub services for pharmaceutical manufacturers
Truepill pricing
Truepill's services now run as FuzeRx, which does not publish prices.
| Plan | Price | What you get |
|---|---|---|
| FuzeRx pharmacy services | On request | Contact Fuze Health |
Checked 15 October 2026 · Official pricing page · Prices change, so confirm before you buy
Who Truepill is for
- telehealth and digital health companies that need a pharmacy partner
- pharmaceutical companies looking for direct-to-patient dispensing
- payers and providers adding home delivery
- individual patients looking for a consumer pharmacy app
- anyone outside the United States
Truepill pros and cons
- Well-known pharmacy partner for telehealth brands
- Now part of a larger company with testing and pharmacy
- API-first integration
- Truepill no longer operates as an independent brand
- No public pricing
Truepill alternatives and how they compare
Other tools and companies often compared with Truepill. We have not compared them hands-on; check each one's own site for current prices.
| Product | What it is | Starts at | Reviews | How it differs from Truepill |
|---|---|---|---|---|
| Truepill this page | White-label digital pharmacy, now part of Fuze Health as FuzeRx | Partner pricing on request (now FuzeRx) | No reviews yet | — |
| Alto Pharmacy | Digital pharmacy with same-day delivery | See its own website | — | Now also part of Fuze Health, focused on direct-to-patient delivery. |
| Capsule | Digital pharmacy with same-day delivery | See its own website | — | Consumer-facing pharmacy in several US cities. |
| Amazon Pharmacy | Amazon's online pharmacy | See its own website | — | Consumer pharmacy rather than a white-label partner. |
Truepill reviews
Write a review
Thanks — share your take?
Frequently asked questions
What happened to Truepill?
LetsGetChecked acquired it in 2024, and the combined company launched as Fuze Health in May 2025. Truepill's pharmacy now runs as FuzeRx.
What did Truepill do?
It filled and shipped prescriptions for telehealth and health brands under their own names, through an API.
How much was Truepill valued at?
Its $142 million Series D in October 2021 valued it at $1.6 billion, Fierce Healthcare reported.
Who founded Truepill?
Y Combinator names Sid Viswanathan as a founder; the company was founded in 2017.
Sources (6), checked 15 October 2026
- FuzeRx (Truepill's website now redirects here)
- Y Combinator: Truepill
- Fierce Healthcare: Truepill's $142M Series D
- MobiHealthNews: Digital pharmacy Truepill scores $142M
- GenomeWeb: Fuze Health launch
- LaingBuisson: Phlo acquires Truepill's UK arm
We list Truepill from public sources and are not affiliated with it. Spotted something wrong? Tell us.